My name is Chris Gibson, Co-Founder and CEO of Recursion, and I'm delighted to welcome you to our Earnings Call this morning ... see REC-7735 at 18.7 mg per case, which is the medium dose ...

In its latest strategy note, ICICI Securities outlines a constructive but cautious view on Indian equities, pegging the Nifty50 base case target ... @nw18.com or call on 02268882347 ...

His administration is considering slashing levies in some cases by more than half in a bid to de-escalate tensions with Beijing, The Wall Street Journal reported Wednesday.

Not only has the country been able to mint its first AI unicorn, Krutrim, but interesting use cases have emerged from the minds of Indian GenAI founders. From leveraging the technology for ...

This page is intended to be a glossary of old and new media terms of relevance to the practice of journalism. To edit or add glossary entries on this page, please click here or email your suggestions ...

Recursion Pharmaceuticals Inc. (RXRX) reported its Q1 2025 financial results, revealing a slight miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of -$0.5 against ...